Furthermore, some key biomarkers such as apolipoprotein E4 (APOE4) were identified as a single greatest genetic risk factor for sporadic AD in clinical settings (Lin et al., 2018; Belloy et al., 2019; Berg et al., 2019). The gene discussed is APOE; the disease is Alzheimer disease.